Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Oct;12(3):253-9.
doi: 10.1007/BF02765106.

Applicator for light delivery and in situ light dosimetry during endobronchial photodynamic therapy: First measurements in humans

Affiliations

Applicator for light delivery and in situ light dosimetry during endobronchial photodynamic therapy: First measurements in humans

L H Murrer et al. Lasers Med Sci. 1997 Oct.

Abstract

This paper presents a design of an applicator for light delivery and light dosimetry during endobronchial photodynamic therapy (EB-PDT). The design incorporates a linear diffuser that is fixed in the centre of the lumen by a steel spring basket that does not block air flow. An isotropic light detector is included in this design, to measure the light fluence actually delivered to the bronchial mucosa surface. The applicator is designed for use with common bronchoscopy equipment, and can be used with bronchoscopes with a large biopsy channel ( approximately 3 mm). The first clinical measurements were performed and caused no additional discomfort to the (nonphotosensitized) patients. The data showed considerable inter-patient variability of the light fluence rate measured as a result of fixed output power of the diffuser. This fact and the expected strong dependence of the fluence rate on the lumen diameter stress the importance of in situ fluence rate measurement for a proper evaluation of the relationship between light fluence and the biological response of EB-PDT.

PubMed Disclaimer

Similar articles

Cited by

  • Photodynamic therapy: the imminent milieu for treating oral lesions.
    Mohanty N, Jalaluddin M, Kotina S, Routray S, Ingale Y. Mohanty N, et al. J Clin Diagn Res. 2013 Jun;7(6):1254-7. doi: 10.7860/JCDR/2013/5767.3088. Epub 2013 Mar 29. J Clin Diagn Res. 2013. PMID: 23905154 Free PMC article.
  • Photodynamic therapy for mesothelioma.
    Hahn SM, Smith RP, Friedberg J. Hahn SM, et al. Curr Treat Options Oncol. 2001 Oct;2(5):375-83. doi: 10.1007/s11864-001-0042-4. Curr Treat Options Oncol. 2001. PMID: 12057100 Review.
  • EGFR-Targeted Photodynamic Therapy.
    Ulfo L, Costantini PE, Di Giosia M, Danielli A, Calvaresi M. Ulfo L, et al. Pharmaceutics. 2022 Jan 20;14(2):241. doi: 10.3390/pharmaceutics14020241. Pharmaceutics. 2022. PMID: 35213974 Free PMC article. Review.

References

    1. Phys Med Biol. 1996 Jun;41(6):951-61 - PubMed
    1. Phys Med Biol. 1995 Nov;40(11):1807-17 - PubMed
    1. Phys Med Biol. 1993 May;38(5):567-82 - PubMed
    1. Photochem Photobiol. 1993 Jul;58(1):92-9 - PubMed
    1. Int J Radiat Oncol Biol Phys. 1991 May;20(5):1061-6 - PubMed